Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mia Pras-Raves

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Inherited Metabolic Disease|November 21, 2014
Principles and practice of lipidomicsFrédéric M Vaz, Mia Pras-Raves, Albert H Bootsma, et al.
Metabolomics : Official Journal of the Metabolomic Society|September 11, 2020
MetaboShiny: interactive analysis and metabolite annotation of mass spectrometry-based metabolomics dataJoanna C Wolthuis, Stefania Magnusdottir, Mia Pras-Raves, et al.
Nature Communications|September 16, 2024
ENCORE: a practical implementation to improve reproducibility and transparency of computational researchAntoine H C van Kampen, Utkarsh Mahamune, Aldo Jongejan, et al.
Nature|March 9, 2017
Interplay between metabolic identities in the intestinal crypt supports stem cell functionMaria J Rodríguez-Colman, Matthias Schewe, Maaike Meerlo, et al.
Human Molecular Genetics|February 25, 2016
Defining functional classes of Barth syndrome mutation in humansYa-Wen Lu, Laura Galbraith, Jenny D Herndon, et al.
The Journal of Biological Chemistry|November 8, 2014
Allosteric inhibition of the neuropeptidase neurolysinChristina S Hines, Kallol Ray, Jack J Schmidt, et al.
JCI Insight|February 22, 2024
The shifting lipidomic landscape of blood monocytes and neutrophils during pneumoniaAlex R Schuurman, Osoul Chouchane, Joe M Butler, et al.
American Journal of Human Genetics|January 20, 2015
CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorderSaskia B Wortmann, Szymon Ziętkiewicz, Maria Kousi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 26, 2020
An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipidsSacha Ferdinandusse, Kirsty McWalter, Heleen Te Brinke, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Inherited Metabolic Disease|November 21, 2014
Principles and practice of lipidomicsFrédéric M Vaz, Mia Pras-Raves, Albert H Bootsma, et al.
Metabolomics : Official Journal of the Metabolomic Society|September 11, 2020
MetaboShiny: interactive analysis and metabolite annotation of mass spectrometry-based metabolomics dataJoanna C Wolthuis, Stefania Magnusdottir, Mia Pras-Raves, et al.
Nature Communications|September 16, 2024
ENCORE: a practical implementation to improve reproducibility and transparency of computational researchAntoine H C van Kampen, Utkarsh Mahamune, Aldo Jongejan, et al.
Nature|March 9, 2017
Interplay between metabolic identities in the intestinal crypt supports stem cell functionMaria J Rodríguez-Colman, Matthias Schewe, Maaike Meerlo, et al.
Human Molecular Genetics|February 25, 2016
Defining functional classes of Barth syndrome mutation in humansYa-Wen Lu, Laura Galbraith, Jenny D Herndon, et al.
The Journal of Biological Chemistry|November 8, 2014
Allosteric inhibition of the neuropeptidase neurolysinChristina S Hines, Kallol Ray, Jack J Schmidt, et al.
JCI Insight|February 22, 2024
The shifting lipidomic landscape of blood monocytes and neutrophils during pneumoniaAlex R Schuurman, Osoul Chouchane, Joe M Butler, et al.
American Journal of Human Genetics|January 20, 2015
CLPB mutations cause 3-methylglutaconic aciduria, progressive brain atrophy, intellectual disability, congenital neutropenia, cataracts, movement disorderSaskia B Wortmann, Szymon Ziętkiewicz, Maria Kousi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 26, 2020
An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipidsSacha Ferdinandusse, Kirsty McWalter, Heleen Te Brinke, et al.
Pageof 1